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Every regulator should be regulated, and this holds true for small RNAs and their associated 
proteins. Knowledge has begun to emerge of the various mechanisms that impose specificity on 
the expression and function of RNA silencing factors. Recent papers, including one in this issue 
of Cell (Paroo et al., 2009), now reveal the posttranslational modifications that take part in the 
regulation of the core RNA silencing factors, Ago, Piwi, and TRBP.Small RNAs of 20–30 nt direct gene regulation through a wide 
range of mechanisms: from DNA methylation and heterochro-
matin formation to mRNA destabilization and translational con-
trol. Through such extensive patrolling over the genome and 
transcriptome, small RNAs are involved in numerous biological 
processes, including developmental timing, cell differentiation, 
cell proliferation, cell death, metabolic control, immunity, and 
transposon silencing (Kim et al., 2009).
A defining feature of small RNAs is their association with Argo-
naute family proteins that act as the effectors in RNA silencing 
(Kim et al., 2009). Argonaute family proteins are classified into two 
clades: Ago and Piwi subfamilies. Based on the types of Argo-
naute proteins that they are associated with and their biogene-
sis pathway, animal small RNAs are grouped into three classes: 
microRNAs (miRNAs), endogenous small-interfering RNAs 
(endo-siRNAs), and piwi-interacting RNAs (piRNAs). MicroRNAs 
are generated from local hairpin structures by the action of two 
RNase III type proteins, Drosha and Dicer. Mature miRNAs of ~22 
nt are then incorporated into Ago subfamily proteins and act as 
posttranscriptional regulators by targeting mRNAs. Piwi-interact-
ing RNAs (24–30 nt in length), on the other hand, are bound to Piwi 
subfamily proteins, are highly abundant in germline cells and func-
tion in transposon silencing through heterochromatin formation 
or RNA destabilization. Endo-siRNAs (~21 nt) have been studied 
mostly in invertebrates, but they have also been found in mouse 
oocytes and embryonic stem (ES) cells. Endo-siRNAs are similar 
to miRNAs in their association with Ago subfamily members and 
their mode of action as posttranscriptional regulators. They differ 
from miRNAs, however, in that they are produced from long dsR-
NAs by Dicer, and in that endo-siRNAs suppress transposable 
elements whereas miRNAs control protein-coding genes.
Recent reports have begun to unveil various ways of regulat-
ing silencing factors. In this Minireview, we will focus on the 
posttranslational modifications of protein factors involved in 
small RNA pathways.
Connections to Cell Signaling: Erk and TRBP
Canonical animal miRNAs are generated via two-step pro-
cessing (Figure 1A). The nuclear RNase III Drosha and its 
cofactor DGCR8/Pasha cleave the primary transcript of an 28 Cell 139, October 2, 2009 ©2009 Elsevier Inc.miRNA gene (pri-miRNA) into a hairpin-structured precur-
sor (pre-miRNA) (Kim et al., 2009). The pre-miRNA is then 
exported to the cytoplasm and gets further processed into 
a mature miRNA of ~22 nt by another RNase III, Dicer. Fol-
lowing Dicer processing, one strand of the RNA duplex is 
loaded onto the RNA-induced silencing complex (RISC) that 
contains the Argonaute protein as the core component.
Dicer forms a processing complex with a partner protein 
containing dsRNA-binding domains (dsRBDs) (Kim et al., 
2009). In Drosophila, Dicer-1 requires Loquacious (Loqs, 
also known as R3D1) for pre-miRNA processing while 
Dicer-2 binds to R2D2 to form a stable complex to gener-
ate siRNAs. Human Dicer interacts with two closely related 
proteins, TRBP (HIV-1 TAR RNA-binding protein) and PACT, 
both of which contain three dsRBDs. Although neither TRBP 
nor PACT is required for the Dicer processing reaction itself, 
they seem to stabilize Dicer and contribute to RISC forma-
tion.
Paroo et al. report in this issue of Cell that TRBP is posi-
tively regulated by the mitogen-activated protein kinase 
(MAPK) pathway (Figure 1B). The study began with the obser-
vation that in western blotting the TRBP protein appeared as 
multiple bands that disappeared upon phosphatase treat-
ment. By mass spectrometry and mutagenesis, the authors 
discovered that the TRBP protein is phosphorylated at four 
serine residues (142, 152, 283, and 286). Computational algo-
rithms predicted that TRBP may be a substrate for one of the 
mitogen-activated protein kinases (MAPKs), Erk, which is a 
major determinant in cellular proliferation, differentiation, 
and survival (Chen et al., 2001). Indeed, TRBP interacted with 
phosphorylated Erk in vivo and was phosphorylated under 
conditions where Erk was activated. In order to reveal the 
physiological function of TRBP phosphorylation, the authors 
generated isogenic cell lines that express wild-type, phos-
pho-mutant, and phopho-mimic TRBPs. Notably, cell line 
expressing phospho-mimic TRBP showed elevated levels of 
TRBP, leading to an increase in the Dicer protein, presum-
ably through protein stabilization. As a consequence of the 
increase in TRBP and Dicer, mature miRNA levels increased. 
Interestingly, most miRNAs (particularly those that facilitate 
Figure 1. Small RNA Pathways and the Posttranslational Modification of Silencing Factors
(A) MicroRNA biogenesis. The primary transcript of an miRNA gene (pri-miRNA) is cropped into pre-miRNA by Drosha and its cofactor DGCR8. The pre-miRNA 
is exported to the cytoplasm by exportin 5 and gets processed by Dicer. As a cofactor of Dicer, TRBP stabilizes Dicer and contribute to RISC formation. One 
strand of the RNA duplex is loaded onto the Ago protein. Four Ago proteins (Ago1–4) are expressed in humans.
(B) Phosphorylation of TRBP (HIV-1 TAR RNA-binding protein). TRBP is phosphorylated at serine residues S142, S152, S283, and S286 in response to Erk path-
way activity. Phosphorylation of TRBP enhances its stability. Its partner, Dicer, is also stabilized, increasing the levels of this processing complex. Consequently, 
most miRNAs are upregulated while anti-growth miRNAs, such as let-7 miRNAs, are downregulated through unknown mechanisms. These changes result in cell 
proliferation and survival. The yellow dots stand for phospho-serine residues in TRBP and green boxes indicate double-stranded RNA-binding domains.
(C) Posttranslational modifications of Ago2. The hydroxylase C-P4H(I) catalyzes hydroxylation at proline 700 of Ago2. Proline hydroxylation stabilizes the Ago2 
protein, facilitating small RNA-guided mRNA cleavage. In addition, Ago2 is phosphorylated via the p38 MAPK pathway. Serine 387 is the major phosphoryla-
tion site. Both the phosphorylation and hydroxylation enhance Ago2 localization to the P body, although the physiological significance of P body localization is 
unclear. Yellow and blue dots represent phosphorylation site and hydroxylation site, respectively. Orange and blue boxes correspond to PAZ and PIWI domains, 
respectively.
(D) Piwi-interacting RNA biogenesis in mouse testes. piRNAs (24–31 nt) are processed from single-stranded RNA precursors that are transcribed from trans-
posons or large piRNA clusters. Primary processing may occur in the cytoplasm because Miwi and Mili are localized in the cytoplasm. Factors that are needed 
for primary processing are unknown. In secondary processing, Mili bound to piRNA (sense strand; blue line) cleaves the complementary precursor (antisense 
strand; red line), defining the 5′ end of a new piRNA. The new piRNA is subsequently passed on to Miwi2. Miwi2, in turn, cleaves the opposite strand precur-
sor, generating the 5′ end of the next piRNA that gets loaded on to Mili. The nuclease that creates the 3′ end of piRNA is unknown. Miwi2 bound to piRNA is 
transported into the nucleus.
(E) Methylation of the Piwi proteins in mice. Piwi proteins are methylated at conserved arginine residues in the N termini by protein methyltransferase PRMT5 
and its cofactor WDR77. (Top) Arginines 74, 95, 100, 146, and 163 are methylated in Mili with the major site at arginine 74. Miwi2 has a putative methylation 
site at the N terminus. Methylated Piwi proteins interact with the indicated Tudor proteins (TDRDs). In fetal testes, TDRD1 induces localization of Miwi2 to a 
cytoplasmic structure called nuage, which is essential for pre-pachytene piRNA production and transposon silencing. (Bottom) Miwi is methylated at arginines 
14 and 49. Although TDRD6 is required for Miwi localization to the chromatoid body, it does not affect pachytene piRNAs. The N termini of Piwi proteins are 
shown. Red dots stand for experimentally validated methylation sites.
(F) Methylation of Piwi proteins in Drosophila. Drosophila Piwi proteins are methylated at conserved arginine residues in the N termini by dPRMT5 and its 
cofactor valois (Drosophila homolog of WDR77). Arginine methylation promotes Piwi protein stability and consequently increases piRNA levels, resulting in 
transposon silencing and germ cell development. Orange and blue boxes correspond to PAZ and PIWI domains, respectively.cell proliferation and growth) were upregulated in the cells 
expressing phospho-mimic TRBP, whereas the let-7 family 
miRNAs, the known suppressor of cell growth, were down-
regulated. Consistently, a specific inhibitor of the Erk path-
way, U0126, decreased pro-growth miRNAs and increased 
anti-growth let-7 miRNAs in several cancer cell lines. Cell 
growth and survival rate were found to be increased in a 
TRBP phosphorylation-dependent manner upon Erk acti-vation. The reason for the suppressive effect on let-7 is 
unclear but it may be that Erk signaling represses let-7 indi-
rectly through regulators such as Lin28 (Dangi-Garimella et 
al., 2009). Thus, the function of the Erk signaling pathway is 
achieved in part through the control of the miRNA biogen-
esis pathway. This study for the first time establishes protein 
modification as the molecular link between an important cell 
signaling pathway and the miRNA machinery.Cell 139, October 2, 2009 ©2009 Elsevier Inc. 29
Hydroxylation and Phosphorylation of Ago2
The first demonstration of a posttranslational modification of 
RNA silencing factors appeared last year. From a proteomic 
analysis of human Ago proteins, Qi et al. found that Ago2 inter-
acts with the subunits of the type I collagen prolyl-4-hydrox-
ylase (C-P4H(I)) (Qi et al., 2008). Mass spectrometry revealed 
that Ago2 is hydroxylated at proline 700. Importantly, hydroxy-
lation enhanced the stability of the Ago2 protein and knock-
down of C-P4H(I) reduced siRNA-induced silencing activity 
(Figure 1C). Putative hydroxylation sites were found in other 
human Ago proteins (Ago1, Ago3, and Ago4) and in mouse and 
fly Ago proteins, but it remains unknown whether Ago hydroxy-
lation is a conserved process.
Apart from stabilizing Ago2, hydroxylation enhanced the 
localization of Ago2 to cytoplasmic foci called P bodies (Qi 
et al., 2008). Of note, Ago2 localization seems to be influ-
enced by phosphorylation as well. Zeng et al. (2008) observed 
that human Ago2 becomes phosphorylated at serine 387 in 
response to the activation of the p38 MAPK pathway. Ago2 
phosphorylation does not alter the level of Ago2 protein, but 
it facilitates the localization of Ago2 to P bodies. P bodies are 
concentrated with RNAs and proteins involved in mRNA decay 
and translational regulation (Eulalio et al., 2007). There is some 
evidence that miRNA- and siRNA-mediated silencing occurs 
in P bodies. However, disruption of the P body does not affect 
silencing, implying that neither P bodies themselves nor Ago2 
localization to the P bodies is essential for the RNAi pathway 
(Eulalio et al., 2007). Therefore, the physiological significance 
of P body localization induced by Ago modification remains 
unclear.
Tudors Join Silencing: Arginine Methylation of Piwi
The second group of Argonaute proteins is the Piwi subfamily 
that takes part in the biogenesis and function of piRNAs in animal 
gonads (Kim et al., 2009). Mice express three Piwi proteins: Mili, 
Miwi, and Miwi2. Drosophila also has three Piwi proteins: Piwi, 
Aub, and Ago3. Piwi-interacting RNAs are processed from single-
stranded RNA precursors that are transcribed from transposons 
or large piRNA clusters. In mice, piRNAs found in pre- and neo-
natal stages (pre-pachytene piRNAs) require Mili and Miwi2 and 
are derived largely from repeat elements. Pre-pachytene piRNAs 
contribute to transposon silencing through DNA methylation and 
possibly RNA cleavage. Piwi-interacting RNAs in adult testes 
(from the pachytene stage of male germ cells) are dependent on 
Mili and Miwi. Pachytene piRNAs are derived mainly from inter-
genic loci in the genome and from piRNA clusters. The function of 
pachytene piRNAs remains unknown.
Piwi-interacting RNA biogenesis involves two distinct mech-
anisms (known as primary and secondary) (Figure 1D) (Aravin 
et al., 2008; Kim et al., 2009; Siomi and Kuramochi-Miyagawa, 
2009). In primary processing, the piRNA precursor is cleaved 
by an unknown enzyme(s) in the cytoplasm and the product is 
loaded on to Mili and Miwi. In secondary processing (known 
as the ping-pong cycle), Mili and Miwi2 use their own endonu-
cleolytic activity to generate and amplify piRNAs. Pachytene 
piRNAs are thought to be generated through primary process-
ing. Pre-pachytene piRNAs are produced through primary pro-
cessing and amplified via the ping-pong cycle.30 Cell 139, October 2, 2009 ©2009 Elsevier Inc.The first indication of Piwi modification came serendipitously 
when Kirino et al. realized that the widely used Y12 monoclo-
nal antibody recognizes Mili and Miwi proteins (Kirino et al., 
2009). Knowing that the epitope of Y12 consists of symmetri-
cally dimethylated arginines (sDMAs), the authors searched for 
sDMA motifs (typically Gly-Arg-Gly) in Piwi proteins and found 
that methylation occurs at conserved sDMA motifs in the N 
terminus of Aub. Most Piwi proteins in mouse, Drosophila, and 
Xenopus contain such sDMA motifs. The precise methylation 
sites in Mili and Miwi were later mapped by other groups by 
mass spectrometry (Reuter et al., 2009; Vagin et al., 2009).
The Drosophila mutant deficient in the protein methyltrans-
ferase 5 gene (dPRMT5, also called capsuleenn [csul] or dart5) 
was known to phenocopy the aub null mutant, implicating a link 
between these two genes. Kirino et al. showed that arginine 
methylation of Piwi proteins was indeed abrogated in dPRMT5-
deficient ovary (Kirino et al., 2009). The protein levels of Aub, 
Ago3, and Piwi were reduced without changes at the mRNA 
levels, suggesting that arginine methylation stabilizes the Piwi 
proteins. The levels of piRNAs also decreased and transpo-
sons were derepressed (Figure 1E).
The Drosophila embryo contains a specialized region known 
as the pole plasm at its posterior end. The pole plasm is 
important for the specification of primordial germ cells (PGCs) 
(Strome and Lehmann, 2007). In dPRMT5-deficient flies, the 
level of Aub in the pole plasm is strongly reduced, suggesting 
that Aub methylation may have an important role in pole plasm 
assembly and PGC formation.
Several questions then followed: what recognizes the 
sDMA in Piwi proteins and what are the consequences of 
sDMA recognition? The answers soon emerged when sev-
eral groups independently carried out purification and pro-
teomic analyses on Piwi complexes (Reuter et al., 2009; 
Vagin et al., 2009). From the analyses of testes from trans-
genic mice expressing epitope-tagged Piwi proteins, Vagin 
et al. found that Piwi complexes contain not only PRMT5 and 
its cofactor WDR77/MEP50/WD45 but also several Tudor 
domain-containing proteins (TDRDs) (Vagin et al., 2009). A 
similar approach, using monoclonal antibody against Mili, 
identified TDRD1 as the interactor (Reuter et al., 2009; Wang 
et al., 2009). Tudor domains are known to recognize methy-
lated arginines, and TDRDs are essential for germ cell devel-
opment in both mouse and fly (Thomson and Lasko, 2005; 
Hosokawa et al., 2007). TDRD1 interacts strongly with Mili, 
but it also binds to Miwi2 and Miwi. Deep sequencing of 
piRNAs from embryonic testes revealed that transposon-
derived pre-pachytene piRNAs were reduced in the Tdrd1-
deficient mice (Vagin et al., 2009), suggesting that TDRD1 
contributes to pre-pachytene piRNA biogenesis. Repeat ele-
ments, such as LINE, were derepressed in the Tdrd1 mutant 
testes (Reuter et al., 2009; Vagin et al., 2009). TDRD1 also 
influences the localization of Miwi2 to a cytoplasmic struc-
ture called nuage that is important for germ cell develop-
ment. In the Tdrd1 mutant, Miwi2 delocalizes from the nuage 
and disperses to the cytoplasm. Consistent with this, the 
transposon-derived piRNAs that are associated with Miwi2 
were more dramatically reduced than other piRNAs (Figure 
1F) (Vagin et al., 2009).
Miwi, on the other hand, interacts with TDRD6 in postnatal 
testes. In round spermatids, Miwi mainly localizes to the chro-
matoid body, a structure related to nuage, and functions in the 
pachytene piRNA pathway along with Mili. In the Tdrd6-defi-
cient mutant, Miwi loses its chromatoid body localization and 
disperses to the cytoplasm. However, the piRNA population is 
not altered, and transposons seem to be unaffected (Vasileva 
et al., 2009). These results suggest that chromatoid body for-
mation may be independent of piRNAs. Some miRNAs were 
found to accumulate in the Tdrd6 mutant (Vasileva et al., 2009), 
but this could be explained by the timing of development in the 
mutant (Vagin et al., 2009). Thus, the significance of the inter-
action between Miwi and TDRD6 is currently unclear.
The sDMA marks on Piwi are read and interpreted by dif-
ferent Tudor domain proteins. Multiple Piwi proteins seem to 
interact with multiple TDRDs (at least six TDRDs were precipi-
tated with mouse Piwi proteins). However, there seems to be a 
certain degree of specificity in the interactions between Piwi 
proteins and TDRDs. It will be necessary to identify the physi-
ological partners of each Piwi protein. It would also be impor-
tant to uncover the biochemical functions of TDRD in order to 
fully understand the role of arginine methylation in the piRNA 
pathway.
Perspectives
An emerging theme in a recent string of literature is that small 
RNA pathways are under intensive regulation. Multiple layers of 
regulation ensure tight control of silencing, and dysregulation 
of small RNAs may lead to human diseases such as cancer, 
myopathy, and neurodegeneration. Posttranslational modifica-
tion has been established as one of the key regulatory layers. 
It will be interesting to further identify new types of modifica-
tions. It will also be important to reveal the upstream signaling 
pathways that affect small RNAs. Developmental and environ-
mental cues need to be accurately transduced to RNA silenc-
ing machinery to maintain the normal cellular function. Many 
miRNAs appear to be controlled posttranscriptionally through 
unknown mechanisms. Such miRNAs may be controlled by cell 
signaling pathways, possibly via posttranslational modification 
of the miRNA machinery. Whether Piwi methylation by PRMT5 
is controlled by external signals also awaits further investiga-
tion. It will be an exciting quest to uncover the missing links 
between cell signaling and RNA silencing.AckNowledgMeNtS
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